Groupe de Recherche Action en Santé (GRAS), Burkina Faso Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT03614533
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Groupe de Recherche Action en Sante | Groupe de Recherche Action en Santé(GRAS) | Groupe de Recherche Action en Santé (GRAS), Burkina Faso

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Typhoid Fever (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6